Skip to main content

Table 1 Effect of Gαq-RGS2 signaling inhibitor on hematological parameters

From: Acute and 28-days subacute toxicity studies of Gαq-RGS2 signaling inhibitor

Parameters

NC

VC

T10

T100

RBC (x106 cells/mm3)

3.745 ± 0.556

3.945 ± 0.556

3.712 ± 0.779

3.583 ± 0.774

Total WBC (x103 cells/mm3)

6.533 ± 1.244

5.833 ± 0.836

6.317 ± 1.036

6.583 ± 1.049

Granulocytes (x103 cells/mm3)

4.885 ± 1.003

5.234 ± 0.668

4.693 ± 0.831

5.53 ± 0.688

Lymphocytes (x103 cells/mm3)

2.033 ± 0.274

2.233 ± 0.287

2.417 ± 0.217

2.383 ± 0.277

Monocytes (x103 cells/mm3)

0.050 ± 0.012

0.057 ± 0.012

0.060 ± 0.011

0.058 ± 0.012

Platelets (x103 cells/µL3)

265.4 ± 39.30

257.4 ± 38.32

248.8 ± 29.10

257.8 ± 42.12

Hb content (g%)

13.48 ± 1.32

13.20 ± 1.07

13.92 ± 1.60

13.35 ± 0.84

  1. NC = Normal control, VC = 1 % DMSO treated normal rats, T10 = Gαq-RGS2 signaling inhibitor (10 mg/kg) treated rats and T100 = Gαq-RGS2 signaling inhibitor (100 mg/kg) treated rats. (n = 6/each group)